BioSpace News Archive

Medicare beneficiaries have the right to receive quality healthcare, whether they are receiving routine care or actively being treated for an acute condition. During the COVID-19 pandemic, Livanta’s resources make it easy for patients and their caregivers to find help in addressing their healthcare concerns.

Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 41st Annual Virtual Global Healthcare Conference on Wednesday, June 10, 2020 at 1:20 p.m. ET . Peter H. Griffith , executive vice president and chief financial officer, and David M. Reese , M.D., executive vice president of Research and Development at Amgen will present

Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced that, due to public health and safety concerns related to the ongoing COVID-19 global pandemic and to support the health and well-bei

Atara Biotherapeutics, Inc . (Nasdaq: ATRA) today announced that, due to public health and safety concerns related to the coronavirus (“COVID-19”) pandemic, recommendations and orders from federal, state and local authorities, and to support the health and well-being of its stockholders, employees, and others, it will host its 2020 Annual Meeting of Stockholders (“Annual Meeting”) as a virtual-only meeti

Castro Valley Health, Inc. has become aware of a data security incident that may have involved some personal information of former patients.

TheU.S. Food and Drug Administration continued to take action in the ongoing response to the COVID-19 pandemic

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, announced it has resumed its pivotal study of Omnipod, Powered by Horizon™, the Company’s personal smart-phone controlled automated insulin delivery system.

Tetra Bio-Pharma Inc. are pleased to announce that they have finalized a definitive commercial sales agreement for the sale of the Mighty Medic device as part of the CAUMZ™-kit drug-device combination product.

Decision Diagnostics Corp. through its subsidiary Pharma Tech Solutions, Inc. made available CEO Keith Berman’s recent interview on radio station CKNW, Vancouver’s #1 rated News/Talk Radio station in the adult 35-64 sector.

RECARBRIO is Indicated to Treat Multiple Infections Caused by Susceptible Gram-Negative Bacteria in Adults